MFDS — authorised 7 May 1982
- Marketing authorisation holder: TEVA PHARMS USA
- Status: likely_approved
🇰🇷 Zanosar in South Korea
MFDS authorised Zanosar on 7 May 1982
Marketing authorisation
Zanosar in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Zanosar approved in South Korea?
Yes. MFDS authorised it on 7 May 1982.
Who is the marketing authorisation holder for Zanosar in South Korea?
TEVA PHARMS USA holds the South Korean marketing authorisation.